FDA.reportPublic FDA data

15 ML mirikizumab-mrkz 20 MG/ML Injection

RxCUI
2668391
RxNorm name
15 ML mirikizumab-mrkz 20 MG/ML Injection
Display name
15 ML mirikizumab-mrkz 20 MG/ML Injection
Full name
15 ML mirikizumab-mrkz 20 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761279Omvohmirikizumab-mrkz351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OmvohMIRIKIZUMAB-MRKZEli Lilly and Company472cbe04-263e-433d-9a0f-58c1b50b715a2026-06-16Warnings, Adverse reactionsExact identifier
rxcui: 2668391

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
472cbe04-263e-433d-9a0f-58c1b50b715amirikizumab-mrkz 300 MG in 15 ML Injection [PSN] · 15 ML mirikizumab-mrkz 20 MG/ML Injection [SCD] · mirikizumab-mrkz 300 MG per 15 ML Injection [SY]318These highlights do not include all the information needed to use OMVOH safely and effectively. See full prescribing information for OMVOH. OMVOH (mirikizumab-mrkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 202320251104